Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy.

导出 LinkOut

翻译打印收藏纠错

作者： Yuki,Yamanishi ^[1] ; Mohammed Emamussalehin,Choudhury ^[2] ; Akira,Yoshida ^[1] ; Yuko,Hosokawa ^[1] ; Noriyuki,Miyaue ^[1] ; Satoshi,Tada ^[1] ; Rina,Ando ^[1] ; Shinobu,Murakami ^[3] ; Hitoshi,Miyamoto ^[3] ; Masahiro,Nagai ^[1]

作者单位： Department of Clinical Pharmacology and Therapeutics Ehime University Graduate School of Medicine Toon Japan. ^[1] Department of Molecular and Cellular Physiology Ehime University Graduate School of Medicine Toon Japan. ^[2] Department of Clinical Laboratory Ehime University Hospital Toon Japan. ^[3]

关键词 LCIG Parkinson's disease intestinal bacteria levodopa pharmacokinetics neuropathology

DOI 10.1002/mdc3.13417

PMID 35402640

发布时间 2023-02-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Movement disorders clinical practice

2022年9卷3期

362-368页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy.

Movement disorders clinical practice

相似文献

Movement disorders clinical practice

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy.

Movement disorders clinical practice

相似文献

Movement disorders clinical practice

相关期刊

检索历史清除